fbpx
QQQ
-0.94
340.28
-0.28%
DIA
-1.26
342.50
-0.37%
SPY
-1.04
417.13
-0.25%
TLT
+ 0.40
139.38
+ 0.29%
GLD
-0.91
169.03
-0.54%

Top 4 Small-Cap Stocks In The Diagnostic Substances Industry With The Highest ROA

by
May 5, 2015 4:51 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of return on assets.

The trailing-twelve-month return on assets at AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is 19.90 percent. AMAG Pharmaceuticals’ revenue for the same period is $124.40 million.

The trailing-twelve-month return on assets at Meridian Bioscience, Inc. (NASDAQ: VIVO) is 19.70 percent. Meridian Bioscience’s PEG ratio is 1.33.

The trailing-twelve-month return on assets at SurModics, Inc. (NASDAQ: SRDX) is 12.40 percent. SurModics’ EPS for the same period is $0.89.

The trailing-twelve-month return on assets at Neogen Corporation (NASDAQ: NEOG) is 8.80 percent. Neogen’s profit margin for the same period is 11.70 percent.

Posted-In:

Trading Ideas

Related Articles

The Daily Biotech Pulse: Vertex Pulls Plug On Protein Deficiency Drug, FDA Nod For Regeneron's Ebola Treatment, Can Fite Issues Psoriasis Readout

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 14) read more

The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) read more

AMAG Pharmaceuticals Shares Fall Sharply Lower; Reuters Reports FDA's Center For Drug Evaluation And Research Proposes Withdrawal of Approval For Co's Makena

-Reuters read more

The Daily Biotech Pulse: Mesoblast Slumps On FDA Rejection, AstraZeneca's Breakthrough Therapy Designation, 3 IPOs

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 1) read more